Key result
Out-of-hospital anticoagulation triggers high decisional conflict in ~98% of high-risk gynecologic oncology patients.
Why the study?
Gynecologic oncology patients with very high VTE risk experience substantial decision-making conflict regarding out-of-hospital anticoagulation, and influencing factors are not well understood.
What are the current status and influencing factors of out-of-hospital anticoagulation decision-making conflict in gynecologic oncology patients with very high VTE risk?
Cross-Sectional (n=188)
Yes
What are the current status and influencing factors of out-of-hospital anticoagulation decision-making conflict in gynecologic oncology patients with very high VTE risk?
Gynecologic oncology patients with very high VTE risk experience substantial decision-making conflict regarding out-of-hospital anticoagulation, which is significantly influenced by their level of VTE knowledge, financial burden, disease duration, and number of hospitalizations.
Answers are grounded in this paper and cite their sources.
High conflict in anticoagulation decisions signals need for support tools; cross-sectional data leaves open intervention efficacy.
Aim To investigate the current status and influencing factors of out‐of‐hospital anticoagulation decision‐making in gynecologic oncology patients with very high venous thromboembolism (VTE) risk. Design This study employs a questionnaire survey to explore the current status of conflicts in outpatient anticoagulation decisions and the influencing factors among patients with very high VTE risk related to gynecologic tumors. Methods This study was conducted in two centers between January and July 2024. A total of 192 questionnaires were distributed, and 188 valid questionnaires were included in the analysis. Data were collected using a general information questionnaire, a VTE knowledge questionnaire, and the Chinese version of the Decisional Conflict Scale (DCS). To avoid overfitting, the dataset was randomly divided into a training set (75%) and a test set (25%). Stepwise multiple linear regression was performed to identify influencing factors. Results The mean DCS score was 57.86 (10.20), and 97.87% of patients experienced high levels of decision‐making conflict. Stepwise multiple linear regression analysis revealed that medical payment method ( β = −0.342, p < 0.001), level of VTE knowledge ( β = −0.615, p < 0.001), number of hospitalizations ( β = 0.176, p < 0.001), and disease duration ( β = 0.090, p = 0.037) were significant influencing factors, collectively explaining 74.3% of the variance in decisional conflict. Conclusion Gynecologic oncology patients with very high VTE risk experience substantial decision‐making conflict regarding out‐of‐hospital anticoagulation. Targeted interventions should focus on improving patient knowledge, reducing financial burden, and addressing the specific needs of patients with longer disease duration and repeated hospitalizations. Implications for the Profession and/or Patient Care This study suggests that clinical medical staff should focus on patients with high levels of decisional conflict, help them clarify doubts, enhance their awareness of VTE prevention, and prevent the occurrence of VTE. Impact (Addressing) This study primarily investigates the decision‐making conflicts regarding anticoagulation in the prevention of VTE among gynecologic cancer patients. This issue is significant because a high rate of decision‐making conflicts related to anticoagulation can lead to decreased awareness among patients about VTE prevention, potentially resulting in an increased incidence of VTE in this patient population. By analyzing the factors that influence the decision‐making conflicts regarding out‐of‐hospital anticoagulation in gynecologic cancer patients, the study aims to explore solutions that can improve VTE management. The research found that gynecological cancer patients who have a new rural cooperative medical payment method, lack understanding of VTE, have higher rates of hospitalization, and experience higher levels of decision‐making conflict. Clinical medical staff should pay attention to patients with these characteristics and provide them with informational and psychological support to reduce decision‐making conflicts, optimize decision quality, enhance awareness of VTE prevention, and standardize clinical VTE management. Patient or Public Contribution No patient or public contribution.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cross-sectional in Gynecologic oncology with very high VTE risk (n=188). Influencing factors (medical payment method, VTE knowledge, hospitalizations, disease duration) was evaluated on Decisional Conflict Scale (DCS) score. Among gynecologic oncology patients with very high VTE risk, 97.87% experienced high levels of decision-making conflict regarding out-of-hospital anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: